Download presentation
Presentation is loading. Please wait.
Published bySabrina Dorsey Modified over 9 years ago
1
Osteosarcoma Clinical and Imaging 5% of primary malignant spinal tumours 4th decade (older than long bone) Associated with Paget’s, DXRT Mixed lytic / sclerotic appearance Aggressive, soft tissue extension Osteoid mineralisation T1WT2W T1W CT Differential diagnosis Ewings Chondrosarcoma Metastasis Osteoblastoma Lymphoma
2
SBTR 4346, AB 22M 7/12 Hx LBP 2/12 Hx right leg / foot pain and weakness more recently urinary problems
3
4346, Ant Bishop, 22M
4
Ewing’s sarcoma Bone or soft tissue Now accepted to be primitive neurectodermal tumour Includes Ewing, PNET, peripheral neuroepithelioma, Askin tumour t (11;22)(q24;q12) and other rearrangements
6
PAS
10
Chimaeric protein Control sequence Control sequence Overexpression of target gene Fusion gene Translocation
11
ES Cytogenetics t(11,22)(q24;q12) (95%)EWS/FLI1 t(21,22)(q22;q12) (5%)EWS/ERG t(7,22)(p22;q12)EWS/ETV1 t(17,22)(q21;q12)EWS/EIAF t(2,22)(q33;q12)EWS/FEV inv(22)(q12;q12)EWS/ZSG t(16,21)(p11;q22)FUS/ERG
12
Ewing’s sarcoma Clinical and Imaging Usually 10 – 30yrs >50% metastases at presentation Metastatic involvement more common than primary Permeative pattern of bone destruction Large soft tissue mass and infiltration No matrix mineralisation but reactive sclerosis MR – inhomogeneous, haemorrhage & necrosis T1W T2WGRE Differential diagnosis Osteosarcoma Osteoblastoma Lymphoma Langerhans
13
30F, LBP
14
T1W T2W
26
Giant Cell Tumour Clinical and Imaging >60% of primary benign sacral tumours 3rd – 5 th decades, 2F:1M Locally aggressive, 12-50% recurrence rate Lytic, expansile, absent matrix, +/- cortical breakthrough CT / MR may show fluid-fluid levels MR – low signal on T2W due to collagen, high cellularity and haemosiderin from haemorrhage Can undergo sarcomatous degeneration Differential diagnosis Expansile metastasis Chordoma Myeloma Aneurysmal bone cyst Osteoblastoma Brown tumour of hyperparathyoidism
27
DH, SBTR 4513 Mid thoracic pain
30
Myeloma Clinical Proliferation of malignant plasma cells Most common primary bone malignancy Most common in 6 th and 7 th decades Plasmacytoma usually precedes myeloma Differential diagnosis Metastases Lymphoma Sarcoma Chordoma GCT
31
Patterns on T1W - Myeloma Baur-Melnyk. Role of MRI in multiple myeloma. EJR 2005; 55:56 <20% plasma cells 20 – 50% plasma cells >50% plasma cells NormalInfiltrationReplacement
32
MC, 1907806113 30F Left neck pain Prominent ECA / pulsatile mass ?carotid body tumour
38
Eosinophilic Granuloma 5 – 10yrs 15% axial skeleton Can be asymptomatic Vertebral body Multifocal in 10% Differential Ewing’s Metastatic neuroblastoma ABC
39
60F, LBP Haemangioma
42
56F, right L5 sciatica
43
Pagets – later phase
44
Paget’s disease of bone increased bone turnover osteoclastic and osteoblastic activity age > 40 M>F 3% of routine autopsies aetiology unknown ? viral racial predilection monostotic or polyostotic raised alkaline phosphatase complications fracture deformity and sarcoma
47
Lolge S. Isolated solitary vertebral body tuberculosis. Clin Rad 2003 22F, Indian Differential diagnosis Sarcoma Eosinophilic granuloma GCT
48
Summary: Imaging In children / adults, metastases most frequent bone tumour. Patient age, location and relative frequency important In sacrum, Paget’s, chordoma and GCT Scintigraphy mainly for staging metastatic disease CT - optimal imaging technique for osteoid osteoma CT - bony detail, mineralisation, cortical shell & sequestra CT - often complementary to MRI. MRI - imaging method of choice.
51
SBTR 4319 Wal Miller chondrosarcoma grade 3
52
GJ, SBTR 4530 LBP, Osteoblastoma
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.